I bought at 77c and have held for a long time. At first I was sceptical of Eshmun's scepticism of NST. Now after the latest report and high ASIC, I am beginning to doubt the company's ability to deliver gold at cheap production costs from their mines. Have management lost their Midas touch that saw them resurrect an old mine like Paulsens and drag many unexpected ounces of gold from it, then buy other mines which seemed promising and maintain a high level of cash? I am not convinced by the Kalgoorlie operation nor their latest venture, the Pogo mine in the USA. I preferred them as a home based company reaping the reward of a declining Australian dollar. Is there anyone who can mount a convincing counter attack to Eshmun's criticism of the NST model? Last time I ignored the advice of a convincing devil's advocate in this forum, I lost over $20000 on QIN. I am not suggesting that NST is another QIN, but I am beginning to doubt the wisdom of holding and not selling while the price is still above $8.
- Forums
- ASX - By Stock
- Ann: December 2018 Quarterly Activities Report
I bought at 77c and have held for a long time. At first I was...
-
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NST (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.61 |
Change
-0.290(1.62%) |
Mkt cap ! $18.16B |
Open | High | Low | Value | Volume |
$18.00 | $18.14 | $17.40 | $158.2M | 8.956M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6356 | $17.58 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.62 | 55910 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 45378 | 9.020 |
6 | 72217 | 9.010 |
4 | 47094 | 9.000 |
7 | 65586 | 8.990 |
8 | 105898 | 8.980 |
Price($) | Vol. | No. |
---|---|---|
9.040 | 46480 | 7 |
9.050 | 128028 | 11 |
9.060 | 115189 | 10 |
9.070 | 48533 | 4 |
9.080 | 64340 | 6 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
NST (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online